Abiopharma

The Funds investment objective is to provide total return, through a combination of capital appreciation and current income Under normal market conditions, the Fund will invest at least 80% of its managed assets in a diversified portfolio of convertible securities and non-convertible income securities. Under normal market conditions, the Fund will invest at least 30% of its managed assets in convertible securities and up to 70% of its managed assets in lower-grade, non-convertible income securities, although the portion of the Funds assets invested in convertible securities and non-convertible income securities will vary from time to time consistent with the Funds investment objective, changes in equity prices and changes in interest rates and other economic and market factors. The Fund may invest without limitation in securities of foreign issuers and the Funds investment in foreign securities may vary over time in the discretion of the Funds investment advisor.

Additional info from NASDAQ:
The Funds investment objective is to provide total return, through a combination of capital appreciation and current income Under normal market conditions, the Fund will invest at least 80% of its managed assets in a diversified portfolio of convertible securities and non-convertible income securities. Under normal market conditions, the Fund will invest at least 30% of its managed assets in convertible securities and up to 70% of its managed assets in lower-grade, non-convertible income securities, although the portion of the Funds assets invested in convertible securities and non-convertible income securities will vary from time to time consistent with the Funds investment objective, changes in equity prices and changes in interest rates and other economic and market factors. The Fund may invest without limitation in securities of foreign issuers and the Funds investment in foreign securities may vary over time in the discretion of the Funds investment advisor.